Based in China, Embracing the World<br>Building a leading innovative pharmaceutical company<br>Benefiting patients and jointly building a healthy future
Based in China, Embracing the World
Building a leading innovative pharmaceutical company
Benefiting patients and jointly building a healthy future

About Us
Suzhou Puhe Biopharma Co., Ltd.
Suzhou Puhe Biopharma Co., Ltd., established in April 2021, represents a collaborative effort between leading domestic medical enterprises and Shiyu Investment, a fund specializing in the pharmaceutical industry. Our core focus is on the development of innovative small molecule drugs in oncology and supportive cancer care. We aspire to be a pioneering BioPharma company with a base in China and a global reach.
Our strategy is to address distinct clinical needs. That's why we focuses on lung cancer, pancreatic cancer, gastrointestinal tumors and other cancer types with high morbidity and mortality rates worldwide. We employ a strategic approach that combines scientific acumen and industrial foresight. Our methods include introducing and developing innovative drug projects, alongside leveraging various means to expand our development opportunities. We are committed to accelerating the industrialization of our company by integrating resources efficiently.
At the heart of our approach are molecular targets, around which we have established a robust platform for developing unique small molecule drugs. This platform integrates advanced technologies like new-generation kinase inhibitors, allosteric inhibitors, synthetic lethality approaches, and Proteolysis targeting chimeras (Protacs) to address complex challenges. Our capabilities span a wide range, from target discovery and molecular structure design to in vivo and in vitro activity assessments, safety and pharmacokinetics evaluations, regulatory submissions, and the initiation of clinical trials across phases I, II, and III, culminating in product production.
Learn More
2021 2021

Year of establishment

50 89 +

Number of patent applications

10 11 +

Patents granted

5 5

Preclinical product pipeline

3 4

Clinical product pipeline

Company Layout
Based in China, Embracing the World
Activated In progress
Beijing
Beijing

Operation Center
Project Management Center

Suzhou
Suzhou

R&D Center
Innovative Preparation Production Center

Henan
Henan

API Production Base
Topical Preparation Production Base

Shanghai
Shanghai

Business Development/Clinical
Innovation Platform

California
California

Overseas Clinical/Business Development
Innovation Platform

New York
New York

Overseas Clinical/Business Development
Innovation Platform

Beijing Suzhou Henan Shanghai California New York
Beijing

Operation Center
Project Management Center

Suzhou

R&D Center
Innovative Preparation Production Center

Henan

API Production Base
Topical Preparation Production Base

Shanghai

Business Development/Clinical
Innovation Platform

California

Overseas Clinical/Business Development
Innovation Platform

New York

Overseas Clinical/Business Development
Innovation Platform

News Center
Get to know valuable industry
updates with Puhe
Learn More
Join Us
Join Our Team
Continuously Challenge the tatus quo
Learn More
Innovation
Innovation
Target Innovation
Product Innovation
Model Innovation
Efficient
Efficient
Result Oriented
Efficient and Pragmatic
Self-driven
Improvement
Improvement
Independent Thinking
Professional and Concentrated
Challenging the Status Quo
Win-Win
Win-Win
Long-term Value
Teamwork
Trust and Sharing